Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Saturday, December 31, 2022.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2022 (2022-12-31): -1263.55%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-465.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-139.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-126.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.13M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-465.02%
3Y Avg
-139.08%
5Y Avg
-126.63%
Market Cap
$51.28M
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-125.67%
3Y Avg
-108.34%
5Y Avg
-82.96%
Market Cap
$51.34M
Return on Invested Capital (ROIC)
-208.76%
TTM Avg
-1171.68%
3Y Avg
-1173.13%
5Y Avg
-939.08%
Market Cap
$51.42M
Return on Invested Capital (ROIC)
-157.40%
TTM Avg
-135.65%
3Y Avg
-123.35%
5Y Avg
-111.97%
Market Cap
$50.78M
Return on Invested Capital (ROIC)
-96.37%
TTM Avg
-130.40%
3Y Avg
-89.09%
5Y Avg
-69.72%
Market Cap
$51.50M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-196.06%
3Y Avg
-152.48%
5Y Avg
-122.21%
Market Cap
$50.37M
Return on Invested Capital (ROIC)
-192.99%
TTM Avg
-98.03%
3Y Avg
-92.21%
5Y Avg
-72.34%
Market Cap
$49.90M
Return on Invested Capital (ROIC)
-26.51%
TTM Avg
-172.21%
3Y Avg
-183.20%
5Y Avg
-141.01%
Market Cap
$49.85M
Return on Invested Capital (ROIC)
-2441.49%
TTM Avg
-1590.42%
3Y Avg
-842.10%
5Y Avg
-573.16%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.13M | N/A | -465.02% | -139.08% | -126.63% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.28M | -63.96% | -125.67% | -108.34% | -82.96% |
| Envoy Medical, Inc. (COCH)vs › | $51.34M | -208.76% | -1171.68% | -1173.13% | -939.08% |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | -157.40% | -135.65% | -123.35% | -111.97% |
| INmune Bio, Inc. (INMB)vs › | $50.78M | -96.37% | -130.40% | -89.09% | -69.72% |
| Clene Inc. (CLNN)vs › | $51.50M | -109.13% | -196.06% | -152.48% | -122.21% |
| Celularity Inc. (CELU)vs › | $50.37M | -192.99% | -98.03% | -92.21% | -72.34% |
| Microbot Medical Inc. (MBOT)vs › | $49.90M | -26.51% | -172.21% | -183.20% | -141.01% |
| Apollomics, Inc. (APLM)vs › | $49.85M | -2441.49% | -1590.42% | -842.10% | -573.16% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | -38.04% | -22.77% | -89.18% | -83.00% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2022-12-31 | -1263.55% |
| 2022-09-30 | -474.91% |
| 2022-06-30 | -282.82% |
| 2022-03-31 | -182.88% |
| 2021-12-31 | -120.95% |
| 2021-09-30 | -80.58% |
| 2021-06-30 | -64.72% |
| 2021-03-31 | -207.75% |
| 2020-12-31 | -132.20% |
| 2020-09-30 | -123.87% |
| 2020-06-30 | -119.54% |
| 2020-03-31 | -117.25% |
| 2019-12-31 | -97.27% |
| 2019-09-30 | -87.50% |
| 2019-06-30 | -73.16% |
| 2019-03-31 | -102.46% |
| 2018-12-31 | -106.45% |
| 2017-06-30 | -61.60% |
| 2017-03-31 | -45.74% |
| 2016-12-31 | -53.76% |
| 2016-09-30 | -50.77% |
| 2016-06-30 | -41.93% |
